|
1
|
Chen ZX, Zhang SJ, Hu HT, Sun BG and Yin
LR: Clinical study of method of strengthening body resistance and
disintoxication in patients with HCC of post-TACE. Zhongguo Zhong
Yao Za Zhi. 32:1211–1213. 2007.(In Chinese). PubMed/NCBI
|
|
2
|
Yin LR, Chen ZX, Zhang SJ, Sun BG, Liu YD
and Huang HZ: Expression of phosphatase and tensin homolog deleted
on chromosome ten in liver of athymic mice with hepatocellular
carcinoma and the effect of Fuzheng Jiedu Decoction. World J
Gastroenterol. 14:108–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun B, Meng J, Xiang T, Chen Z, Li Y, Lu
L, Zhang S and Chen X: Jianpijiedu fang improves survival of
hepatocarcinoma mice by affecting phosphatase and tensin homolog,
phosphoinositide 3-kinase and focal adhesion kinase. J Tradit Chin
Med. 33:479–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taylor AK, Cao W, Vora KP, De La Cruz J,
Shieh WJ, Zaki SR, Katz JM, Sambhara S and Gangappa S: Protein
energy malnutrition decreases immunity and increases susceptibility
to influenza infection in mice. J Infect Dis. 207:501–510. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Finn OJ: Cancer Immunology. N Engl J Med.
358:2704–2715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valdés-Ramos R and Benítez-Arciniega AD:
Nutrition and immunity in cancer. Br J Nutr. 98(Suppl 1):
S127–S132. 2007.PubMed/NCBI
|
|
7
|
Zhang M, Maiti S, Bernatchez C, Huls H,
Rabinovich B, Champlin RE, Vence LM, Hwu P, Radvanyi L and Cooper
LJ: A new approach to simultaneously quantify both TCR α- and
β-chain diversity after adoptive immunotherapy. Clin Cancer Res.
18:4733–4742. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang QJ, Hanada K, Feldman SA, Zhao Y,
Inozume T and Yang JC: Development of a genetically-modified novel
T-cell receptor for adoptive cell transfer against renal cell
carcinoma. J Immunol Methods. 366:43–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JA, Rao P, Graor H, Rothchild K,
O'keefe C and Maciejewski JP: CDR3 spectratyping identifies clonal
expansion within T-cell subpopulations that demonstrate therapeutic
antitumor activity. Surgery. 136:295–302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Islam S, Abély M, Alam NH, Dossou F,
Chowdhury AK and Desjeux JF: Water and electrolyte salvage in an
animal model of dehydration and malnutrition. J Pediatr
Gastroenterol Nutr. 38:27–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duarte FO, Sene-Fiorese M, Cheik NC, Maria
AS, de Aquino AE Jr, Oishi JC, Rossi EA, de Garcia Oliveira, Duarte
AC and Dâmaso AR: Food restriction and refeeding induces changes in
lipid pathways and fat deposition in the adipose and hepatic
tissues in rats with diet-induced obesity. Exp Physiol. 97:882–894.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Editorial Committee of Chinese Herbs,
State Administration of Traditional Chinese Medicine of the
People's Republic of China. A Selection of Chinese Herbal
Medicines. I:(Shanghai). Shanghai Science and Technology Press.
57–60. 1998.(In Chinese).
|
|
13
|
Gong LS, Zhang YD and Liu S: Target
distribution of magnetic albumin nanoparticles containing
adriamycin in transplanted rat liver cancer model. Hepatobiliary
Pancreat Dis Int. 3:365–368. 2004.PubMed/NCBI
|
|
14
|
Chen JH, Ling R, Yao Q, Wang L, Ma Z, Li
Y, Wang Z and Xu H: Enhanced antitumor efficacy on hepatoma-bearing
rats with adriamycin-loaded nanoparticles administered into hepatic
artery. World J Gastroenterol. 10:1989–1991. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Douillard P, Pannetier C, Josien R,
Menoret S, Kourilsky P, Soulillou JP and Cuturi MC: Donor-specific
blood transfusion-induced tolerance in adult rats with a dominant
TCR-Vbeta rearrangement in heart allografts. J Immunol.
157:1250–1260. 1996.PubMed/NCBI
|
|
16
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Venturi V, Kedzierska K, Turner SJ,
Doherty PC and Davenport MP: Methods for comparing the diversity of
samples of the T cell receptor repertoire. J Immunol Methods.
321:182–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kirkham A, Haley J, Haile Y, Grout A,
Kimpton C, Al-Marzouqi A and Gill P: High-throughput analysis using
AmpFlSTR® Identifiler® with the Applied Biosystems 3500xl Genetic
Analyzer. Forensic Sci Int Genet. 7:92–97. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hulce D, Li X, Snyder-Leiby T, Johathan CS
and Liu GeneMarker®: Genotyping Software: Tools to Increase the
Statistical Power of DNA Fragment Analysis. J Biomol Tech.
22(Suppl): S35–S36. 2011.
|
|
20
|
Lu J, Basu A, Melenhorst JJ, Young NS and
Brown KE: Analysis of T-cell repertoire in hepatitis-associated
aplastic anemia. Blood. 103:4588–4593. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldstein G and Audhya TK: Thymopoietin to
thymopentin: Experimental studies. Surv Immunol Res. 4(Suppl 1):
1–10. 1985.PubMed/NCBI
|
|
22
|
Reggiani PC, Morel GR, Cónsole GM,
Barbeito CG, Rodriguez SS, Brown OA, Bellini MJ, Pléau JM, Dardenne
M and Goya RG: The thymus-neuroendocrine axis: Physiology,
molecular biology and therapeutic potential of the thymic peptide
thymulin. Ann NY Acad Sci. 1153:98–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Ke XY, Khara JS, Bahety P, Liu S,
Seow SV, Yang YY and Ee PL: Synthetic modifications of the
immunomodulating peptide thymopentin to confer anti-mycobacterial
activity. Biomaterials. 35:3102–3109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Petronella P, Ferrone R, Freda F and
Valeriani G: Thymopentin and immune response in patients with
cancer. Minerva Chir. 44:2017–2020. 1989.(In Italian). PubMed/NCBI
|
|
25
|
Li T, Li ZW and Wen HC: Study on the
efficacy and safety of high dose thymopentin combined with
trans-artery chemoembolization for primary liver cancer. Zhonghua
Zhong Liu Za Zhi. 29:941–942. 2007.(In Chinese). PubMed/NCBI
|
|
26
|
Li J, Cheng Y, Zhang X, Zheng L, Han Z, Li
P, Xiao Y, Zhang Q and Wang F: The in vivo immunomodulatory and
synergistic anti-tumor activity of thymosin α1-thymopentin fusion
peptide and its binding to TLR2. Cancer Lett. 337:237–247. 2013.
View Article : Google Scholar : PubMed/NCBI
|
